We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Randomized Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00175175
First Posted: September 15, 2005
Last Update Posted: September 15, 2006
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Collaborators:
Alberta Heritage Foundation for Medical Research
Royal Alexandra Hospital
Information provided by:
University of Alberta
  Purpose

Patients with hip fractures have suffered the most devastating consequence of osteoporosis; and yet, they are rarely if ever tested or treated for the condition, even though they remain at high risk of recurrent fracture.

We hypothesize that, compared with usual care, an allied health professional-run osteoporosis service (case management) will be able to increase testing and treatment of osteoporosis in patients at high risk of fracture.


Condition Intervention
Osteoporosis Hip Fracture Behavioral: Allied health professional-run osteoporosis service ("case-management")

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: Single
Primary Purpose: Treatment
Official Title: Randomized Trial of Osteoporosis Intervention Strategies in Hip Fracture Patients

Resource links provided by NLM:


Further study details as provided by University of Alberta:

Primary Outcome Measures:
  • The proportion of patients taking bisphosphonate therapy within 6 months of hip fracture

Secondary Outcome Measures:
  • Proportion of patients taking prescription osteoporosis treatment at 6 months and 12 months
  • Proportion in receipt of a BMD test at 6 months and 12 months
  • Proportion still adherent to osteoporosis treatments at 6 months and 12 months
  • Proportion of patients with recurrent fractures at 6 months and 12 months
  • Cost effectiveness analyses

Estimated Enrollment: 220
Study Start Date: March 2002
Detailed Description:

Patients with hip fractures have suffered the most devastating consequence of osteoporosis; and yet, they are rarely if ever tested or treated for the condition, even though they remain at high risk of recurrent fracture.

We hypothesize that, compared with usual care, an allied health professional-run osteoporosis service (case management) will be able to increase testing and treatment of osteoporosis in patients at high risk of fracture.

  Eligibility

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   50 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • hip fracture patient > 50 years of age
  • able to give consent (or proxy consent available)
  • lives within health region
  • no contraindications to bisphosphonate therapy

Exclusion Criteria:

  • refuses to participate or consent
  • dementia or delirium without a proxy consent available
  • nursing home or longterm care
  • pathologic fracture
  • chronic glucocorticoid use
  • already receiving prescription osteoporosis treatment (calcium and vitamin D do not preclude inclusion)
  Contacts and Locations
Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00175175


Locations
Canada, Alberta
University of Alberta Hospitals
Edmonton, Alberta, Canada, T6G 2B7
Sponsors and Collaborators
University of Alberta
Alberta Heritage Foundation for Medical Research
Royal Alexandra Hospital
Investigators
Principal Investigator: Sumit R Majumdar, MD, MPH University of Alberta
  More Information

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
ClinicalTrials.gov Identifier: NCT00175175     History of Changes
Other Study ID Numbers: AHFMR #200100791
First Submitted: September 9, 2005
First Posted: September 15, 2005
Last Update Posted: September 15, 2006
Last Verified: September 2006

Keywords provided by University of Alberta:
osteoporosis treatment
osteoporosis testing
hip fracture
quality improvement

Additional relevant MeSH terms:
Fractures, Bone
Osteoporosis
Hip Fractures
Wounds and Injuries
Bone Diseases, Metabolic
Bone Diseases
Musculoskeletal Diseases
Metabolic Diseases
Femoral Fractures
Hip Injuries
Leg Injuries